PRESS RELEASE published on 10/08/2024 at 17:45, 1 year 10 months ago Affluent Medical Announces Participation in Upcoming Scientific Events. Affluent Medical to participate in EACTS 2024, ICS 2024, and PCR London Valves scientific conferences showcasing its innovative medical devices. CEO Ladet looks forward to discussing future partnerships and advancements Innovation Medical Devices Affluent Medical Partnerships Scientific Conferences
BRIEF published on 10/07/2024 at 17:50, 1 year 10 months ago Affluent Medical: Status of shares and voting rights as of September 30, 2024 Euronext Paris Share Capital Voting Rights Actions Affluent Medical
BRIEF published on 09/26/2024 at 17:50, 1 year 10 months ago Affluent Medical SA Achieves Major Milestones in H1 2024 Financial Results Epygon Valve Strategic Agreements Kalios™ Artus Pilot Study
PRESS RELEASE published on 09/26/2024 at 17:45, 1 year 10 months ago Affluent Medical SA: H1 2024 RESULTS - Major advances in all three programs - Several strategic agreements signed with the world medtech leader in cardiology - Extension of financial runway Affluent Medical SA reports major advances in all three programs in H1 2024, signs strategic agreements with medtech leader, and extends financial runway. Detailed financial results available on the website Strategic Agreements H1 2024 Results Affluent Medical SA Medtech Leader Financial Runway
PRESS RELEASE published on 09/26/2024 at 17:45, 1 year 10 months ago Affluent Medical : H1 2024 results. French medical technology company, Affluent Medical, releases H1 2024 results including advances in programs, strategic agreements, and financial extension to July 2025 Medical Devices Affluent Medical Financial Extension Strategic Agreements H1 2024 Results
BRIEF published on 09/12/2024 at 18:49, 1 year 11 months ago Affluent Medical presents its operational advances Medical Devices Funding Partnership Clinical Trials Affluent Medical
PRESS RELEASE published on 09/12/2024 at 18:44, 1 year 11 months ago Affluent Medical : Affluent Medical takes stock of its recent operational advances Affluent Medical reports recent operational advances including agreements with Edwards Lifesciences for medical devices Kalios, Epygon, and Artus. Analysts target price of €4.04 revised upwards Medical Devices Affluent Medical Target Price Edwards Lifesciences Operational Advances
BRIEF published on 09/10/2024 at 17:50, 1 year 11 months ago Affluent Medical: Balance sheet of shares and voting rights as of July 31, 2024 Share Capital Voting Rights Actions AMF Affluent Medical
BRIEF published on 09/10/2024 at 17:50, 1 year 11 months ago Affluent Medical: number of shares and voting rights as of August 31, 2024 Euronext Paris Share Capital Voting Rights AMF Affluent Medical
BRIEF published on 08/22/2024 at 07:35, 1 year 11 months ago Affluent Medical to Attend German Fall Conference in Frankfurt in September 2024 Affluent Medical Innovative Medical Devices German Fall Conference Christophe De Vregille Financial Milestones
Published on 08/12/2026 at 15:42, 4 hours 31 minutes ago Critical Elements 10,000-Meter Summer Drill Program at Rose West Resumes with Positive Results
Published on 08/12/2026 at 15:00, 5 hours 13 minutes ago Karbon-X and Core Energy Sign Letter of Intent to Explore Commercial EV Charging Infrastructure in South America
Published on 08/12/2026 at 14:45, 5 hours 28 minutes ago Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 08/12/2026 at 14:00, 6 hours 13 minutes ago International Battery Metals Appoints Scott Colangelo to Board of Directors
Published on 08/12/2026 at 19:57, 15 minutes ago EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million
Published on 08/12/2026 at 19:37, 35 minutes ago EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged
Published on 08/12/2026 at 18:17, 1 hour 56 minutes ago EQS-Adhoc: Gateway Real Estate AG resolves segment change from the regulated market (Prime Standard) to the Scale segment of the open market (Freiverkehr) on the Frankfurt Stock Exchange
Published on 08/10/2026 at 18:00, 2 days 2 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 2 days 8 hours ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 2 days 8 hours ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 2 days 10 hours ago Number of shares and voting rights - July 2026 (In French only)